ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

ScripsAmerica's specialty pharmacy operations recorded approved orders of $1,136,000 during the month of August and $1,680,000 during September of 2015. This represents 48% month over month growth in revenue from our specialty pharmacy to close the third quarter.

It is nice to see numbers again. Although I find it eyebrow-raising that SCRC failed to report its JUL numbers but simply pointed to AUG and then again to SEP and making sure everyone knew that SEP was higher than AUG.

Without knowing what JUL is, we can logically surmise that it was likely pretty bad -- otherwise SCRC would have disclosed it. As such, we can probably estimate Q3 to be in the $3.5-$3.8M range.

So here are the past 4 quarters:

Q4'14 = $16.2M
Q1'15 = $8.7M
Q2'15 = $5.7M
Q3'15 = $3.5-$3.8M

But, the important thing is that the number is now going up after a terrible year of decline.

If SCRC wants to rebuild its reputation and make the market believe that it has turned over a new leaf and has abandoned its misleading and deceptive ways, it needs to be forthright about ALL of its numbers EACH AND EVERY MONTH going forward. The ommission of JUL numbers in this very PR tells the market that SCRC is still playing deceptive games.

We need to see NEXT month's numbers ON TIME as well as the month after. These next two monthly numbers need to reflect robust month-over-month growth -- otherwise, this bump from AUG to SEP will be shown to be nothing more than a one-time aberration.

As a result of these efforts, ScripsAmerica has formed multiple new marketing relationships in the specialty pharmacy industry that have already begun and we believe will continue contributing to the growth of our monthly approved orders and revenue.

This further supports what I have been saying in that the 10K is no longer relevant (BUT, it will likely still be pumped to high heaven by SCRC's own officially company-endorsed homophobic criminal JOSEPH ZAMPETTI and his fellow criminal CORE members -- especially the Ukranian one). In fact, the Q1 10Q and Q2 10Q are also equally meaningless.

The only data point that will be of value in either the 10K or the Q1 10Q or the Q2 10Q is the official validation of the share structure to corroborate what has been PR'd, so that market participants can at least know what it is they are buying into.

What is relevant now is to see a timely 10Q for Q3 so we can see what the earnings impact is of this new revenue run rate. In addition, these "multiple new marketing relationships" tell me that commissions expense is likely to be high again as Main Ave is NOT growing its numbers organically but only doing so via 3rd party arrangements whereby these 3rd parties will now also need to be compensated for bringing the orders to Main Ave.

With fixed costs eating up a bigger and bigger portion of the small revenue pie, even if SCRC generates $20M/year in revenues, a 5% earnings rate translates to $1M in net income. Spread amongst 140M shares, this computes to approx .007 per share in EPS. A generous 10x multiple would bring the sp to only .07 -- assuming the market is willing to award SCRC a 10x multiple w/o at least 2 consecutive timely-filed 10Q's to demonstrate a consistent pattern of growth of the top line as well as an acceptable level of profitability.

As it stands, it is clear that since the PR 5 days ago, we still have barely seen $50k worth of shares traded, and...

...remember, almost 14M shares were traded down at the .02x levels, so there is no shortage of shareholders eager and willing to cash in... ...and when that happens, these 14M shares are locked and loaded waiting to create resistance that will make it a task worthy of Job himself to wait out the churning of these shares at the .035-.04 levels.

I have stated for quite some time that SCRC is a trading stock that moves primarily based upon technicals and PR's, and it is not a coincidence that the PR came at a time when the technical indicators began indicating that a turn upward was due. Strength and direction indicators at Barchart.com confirm this.

What is noteworthy to keep an eye out on is the fact that the sp has jumped so much this week (from a percentage standpoint) on very little volume AND by leaving so many huge gaps. The sp has literally jumped in nearly 10% increments from one trade to the next on several occasions. And those who are savvy market participants quickly recognize this as a major red flag that screams out "CAUTION".

Now would be a good time for an unexpected 10K or other material good news to piggyback off of this PR; otherwise, any extended period of no news will result in stagnation and another slow bleed.

GLTA...